XTend Medical has signed an exclusive worldwide distribution deal for DDI's vibration device, which is used to pre-screen patients with diabetic neuropathy. XTend will launch the device in the U.S. after it secures FDA approval and plans to expand into the European and South Korean markets.

Full Story:

Related Summaries